230 related articles for article (PubMed ID: 7324079)
21. Hepatitis E virus as an etiology of acute exacerbation of previously unrecognized asymptomatic patients with hepatitis B virus-related chronic liver disease.
Kumar M; Sharma BC; Sarin SK
J Gastroenterol Hepatol; 2008 Jun; 23(6):883-7. PubMed ID: 18070014
[TBL] [Abstract][Full Text] [Related]
22. [Electron microscopic study of the sera of hepatitis B surface antigen (HBs Ag) subjects (author's transl)].
Monges B; Remacle JP; Monges G; Payan H
Pathol Biol (Paris); 1981 Mar; 29(3):143-9. PubMed ID: 7017557
[TBL] [Abstract][Full Text] [Related]
23. [De novo hepatitis B infection after liver transplantation--evidence for the need of active hepatitis B vaccination of liver transplantation candidates].
Rambusch EG; Nashan B; Tillmann HL; Böker KH; Schlitt HJ; Maschek H; Raab R; Manns MP
Z Gastroenterol; 1998 Dec; 36(12):1027-35. PubMed ID: 10025054
[TBL] [Abstract][Full Text] [Related]
24. [Materno-fetal transmission of hepatitis B virus in Ivory Coast. Plea for mass vaccination].
Lohouès-Kouacou MJ; Touré M; Hillah J; Camara BM; N'Dri N; Kouamé KJ; Attia Y
Sante; 1998; 8(6):401-4. PubMed ID: 10064911
[TBL] [Abstract][Full Text] [Related]
25. [Healthy and pseudo-healthy carriers of hepatitis B virus. A comparative clinical, biological and pathological approach].
Debonne JM; Klotz F; Parzy D; Hovette P; Martet G; Aubry P
Ann Med Interne (Paris); 1992; 143(3):160-4. PubMed ID: 1524350
[TBL] [Abstract][Full Text] [Related]
26. Clinical impact and efficacy of lamivudine therapy in de novo hepatitis B infection after liver transplantation.
Castells L; Vargas V; Rodríguez F; Allende H; Buti M; Sánchez-Avila JF; Jardí R; Margarit C; Pumarola T; Esteban R; Guardia J
Liver Transpl; 2002 Oct; 8(10):892-900. PubMed ID: 12360430
[TBL] [Abstract][Full Text] [Related]
27. [Hepatopathies associated with chronic carriage of HBs antigen in black African immigrants in France].
Meyniel D; Santoni JP; Gessain A; Grivaux M; Chatelet F; Pieron R
Sem Hop; 1983 Oct; 59(35):2465-70. PubMed ID: 6314528
[TBL] [Abstract][Full Text] [Related]
28. Intrahepatic expression of hepatitis B virus antigens: effect of hepatitis C virus infection.
Guido M; Thung SN; Fattovich G; Cusinato R; Leandro G; Cecchetto A; Cesaro S; Panese P; Rugge M
Mod Pathol; 1999 Jun; 12(6):599-603. PubMed ID: 10392636
[TBL] [Abstract][Full Text] [Related]
29. Results of long-term prospective study of the hepatitis B surface antigen (HBsAg) carrier state.
Feinman SV; Berris B; Cooter N; Sinclair JC; Wrobel DM
Hepatogastroenterology; 1982 Apr; 29(2):58-61. PubMed ID: 7084885
[TBL] [Abstract][Full Text] [Related]
30. HBe-Antigen in the course and prognosis of hepatitis B infection: a prospective study.
Schulman AN; Fagen ND; Brezina M; Silver H; Nitzze A; Morton D; Gitnick GL
Gastroenterology; 1980 Feb; 78(2):253-8. PubMed ID: 7350048
[TBL] [Abstract][Full Text] [Related]
31. Long-term follow-up of hepatitis B virus carriers with normal transaminases levels.
Koçak N; Ozen H; Yüce A; Gürakan F
Turk J Pediatr; 1998; 40(3):365-72. PubMed ID: 9763900
[TBL] [Abstract][Full Text] [Related]
32. Peritoneoscopic liver biopsy findings in asymptomatic chronic HBsAg carriers with normal liver function tests and no hepatomegaly.
Chon CY; Han KH; Lee KS; Moon YM; Kang JK; Park IS; Park C
Yonsei Med J; 1996 Oct; 37(5):295-301. PubMed ID: 8997161
[TBL] [Abstract][Full Text] [Related]
33. [Clinico-prognostic significance of partial seroconversion in chronic viral hepatitis B follow-up. Wartenbert Study (1974-1994), II].
Ohlen I; Liegl JM; Selmair H
Leber Magen Darm; 1995 Dec; 25(6):259-62. PubMed ID: 8577215
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis B virus carrier with low titer of antibody to hepatitis B core antigen.
Naito M; Matsuda H; Okuno H; Kim H; Azuma M; Kashiwagi T; Mitsutani N; Koizumi T; Kawaguchi G; Kobayashi Y
Hepatogastroenterology; 1994 Jun; 41(3):235-8. PubMed ID: 7959545
[TBL] [Abstract][Full Text] [Related]
35. [Practical use and interpretation of viral hepatitis B markers and hepatic biopsy in HBs Ag carriers and at the chronic hepatitis stage].
Gras C; Aubry P; Oddes B; Martet G; Branquet D
Bull Soc Pathol Exot Filiales; 1985; 78(5 Pt 2):890-5. PubMed ID: 3836777
[TBL] [Abstract][Full Text] [Related]
36. Histopathologic and immunohistochemic correlations in virus B chronic hepatitis.
Comănescu V; Ardeleanu C; Zaharia B; Florescu M; Simionescu C; Comănescu C
Rom J Morphol Embryol; 1997; 43(3-4):169-72. PubMed ID: 9747117
[TBL] [Abstract][Full Text] [Related]
37. Chronic hepatitis B virus carriers in the immunotolerant phase of infection: histologic findings and outcome.
Andreani T; Serfaty L; Mohand D; Dernaika S; Wendum D; Chazouillères O; Poupon R
Clin Gastroenterol Hepatol; 2007 May; 5(5):636-41. PubMed ID: 17428739
[TBL] [Abstract][Full Text] [Related]
38. Role of hepatitis B virus in non-B, non-C chronic liver disease: in vitro proliferation and interferon-gamma production of peripheral blood mononuclear cells in response to hepatitis B core antigen and its relation to hepatitis activity.
Niigaki M; Fukuda R; Hamamoto S; Ishimura N; Ishihara S; Akagi S; Watanabe M; Kinoshita Y
Am J Gastroenterol; 2000 Jan; 95(1):239-47. PubMed ID: 10638591
[TBL] [Abstract][Full Text] [Related]
39. Clinical and prognostic values of anti-hepatitis B core immunoglobulin M detection in asymptomatic hepatitis B surface antigen carriers.
Ali HY; Faransawy ZE; Al-Megthab NA
Saudi Med J; 2002 Jul; 23(7):777-81. PubMed ID: 12174223
[TBL] [Abstract][Full Text] [Related]
40. The majority of hepatitis B carriers are not on regular surveillance in Singapore.
Wai CT; Mak B; Chua W; Lim SG
Singapore Med J; 2004 Sep; 45(9):423-6. PubMed ID: 15334285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
